The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women

Royer, Monique; Castelo-Branco, Camil; Blümel, Juan E.; Chedraui, Peter; Danckers, Luis; Bencosme, Ascanio; Navarro, Daysi; Vallejo, Soledad; Espinoza, María T.; Gómez, Gustavo; Izaguirre, Humberto; Ayala, Félix; Martino, M U De; Ojeda, Eliana; Onatra, William; Huamán-Saavedra, Juan Jorge; Tserotas, Konstantinos; Pozzo, Estela; Manrı́quez, V.; Prada, Mariela; Grandia, Elena; Zuñiga, Cristina; Lange, Diego; Sayegh, Fabiana

doi:10.1080/13697130701258895

Cited by 96 publications

(56 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Considering the criteria for METS recommended by the International Diabetes Federation 9 (waist circumference 80 cm and FPG 100 mg/dl), the prevalence of METS in Brazilian postmenopausal women was 61.4%. All these rates are higher than results reported for women from other Latin America countries by the Collaborative Group for Research of the Climacteric in Latin America 1 . Thus, Brazilian postmenopausal women constitute a population with increased risk for cardiovascular disease.…”

contrasting

confidence: 50%

“…We read with great interest the recent manuscript, by the Collaborative Group for Research of the Climacteric in Latin America, on the prevalence of metabolic syndrome (METS) and its components in postmenopausal Latin American women 1 . The authors analyzed the prevalence of METS according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP) 2 in a total of 3965 postmenopausal women, aged 45-64 years, and observed a high prevalence of METS, ranging from 28.1% in women aged 40-44 years to 42.9% in those aged 60-64 years.…”

mentioning

confidence: 99%

“…After menopause, the risk of developing CHD increases significantly and METS emerges as a constellation of risk factors including hypertension, increase in abdominal fat (adiposity), abnormal lipoprotein levels, and insulin resistance, all of which appear to occur with estrogen deficiency 4,5 . In the cited article 1 , only Latin American women of Hispanic origin were assessed and no data on the Brazilian population were included. Brazil, a country of continental dimensions, has about 15 million postmenopausal women and widely diverse regions in terms of dietary habits and human development indicators 6 .…”

mentioning

confidence: 99%

See 2 more Smart Citations

Metabolic syndrome in postmenopausal women: higher prevalence in the Northeastern Region of Brazil than in other Latin American countries and the influence of obesity and socioeconomic factors

Silveira¹,

Maranhão²,

Azevedo³

2007

Climacteric

View full text Add to dashboard Cite

contrasting

confidence: 50%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Metabolic syndrome in postmenopausal women: higher prevalence in the Northeastern Region of Brazil than in other Latin American countries and the influence of obesity and socioeconomic factors

Silveira¹,

Maranhão²,

Azevedo³

2007

Climacteric

View full text Add to dashboard Cite

“…La prevalencia de síndrome metabólico es cada vez mayor entre mujeres postmenopausicas no solo en España (Llisterri et al, 2009) sino también en Latinoamérica (Royer et al, 2007). Aunque en la actualidad existen diferentes clasificaciones diagnósticas, todas coinciden en reconocer la importancia de la obesidad abdominal o central en el origen y progresión del síndrome metabólico (Després et al, 2008).…”

Section: Introductionunclassified

Correlaciones entre Marcadores de Grasa Abdominal Obtenidos por Densitometría y Técnicas Antropométricas Convencionales en Mujeres Postmenopausicas con Síndrome Metabólico

et al. 2013

View full text Add to dashboard Cite

RESUMEN:El presente estudio pretende identificar correlaciones estadísticamente significativas entre parámetros de masa grasa abdominal obtenidos por densitometría (DXA) y otros de tipo cineantropométrico (índices de distribución de masa grasa) y bioquímico (perfil lipídico) en mujeres postmenopausicas con síndrome metabólico. Se diseño un estudio de cohortes histórico que incluyó a un total de 1326 mujeres post-menopausicas con edad > 45 años que se habían sometido rutinariamente a DXA para conocer su densidad mineral ósea entre Enero de 2006 y Enero de 2011. Se utilizó un DXA tipo Lunar DPX-L para determinar la masa grasa abdominal en las regiones de interés L1-L4 y L3-L4. Además del DXA, se obtuvo de cada participante la correspondiente anamnesis, bioquímica, tensión arterial e índices de distribución de masa grasa mediante técnicas antropométricas convencionales. Se utilizó la clasificación NCEP-ATP-III para el diagnóstico de síndrome metabólico. Este protocolo fue aprobado por un Comité de Ética Institucional. La mayor fuerza de asociación se estableció entre el porcentaje de masa grasa L1-L4 obtenido por DXA y el perímetro de la cintura (r= 0,77; p= 0,0016) además de con colesterol-HDL (r= -0,58; p= 0,0290). Finalmente se concluye que el perímetro de la cintura y los niveles de colesterol-HDL podrían recomendarse como predictores del comportamiento de la masa grasa abdominal de regiones de interés L1-L4 y L3-L4 obtenidas por DXA en mujeres postmenopausicas con síndrome metabólico. et al., 2007). Aunque en la actualidad existen diferentes clasificaciones diagnósticas, todas coinciden en reconocer la importancia de la obesidad abdominal o central en el origen y progresión del síndrome metabólico (Després et al., 2008). En este sentido, los adipocitos de la grasa abdominal o central o visceral jugarían un papel más importante que la subcutá-nea en la secreción de citokinas proinflamatorias (adipokinas) como demuestran los mayores niveles de ARNm presentes en aquellos (Després et al.; Philips & Prins, 2008).En los últimos años ha aumentado el interés por estudiar el comportamiento de la masa grasa abdominal en el manejo clínico de esto pacientes (Kishida et al., 2012; Philips et al., 2013). Las técnicas cineantropométricas convencionales siguen siendo usadas gracias a su bajo coste y disponibilidad en cualquier entorno clínico (Oda et al., 2010). Sin embargo este tipo de herramientas presenta limitaciones como no poder diferenciar masa grasa visceral de la subcutánea a pesar de su diferente rol en la fisiopatología del síndrome metabólico (Bouchard, 2007). También ofrece una limitada capacidad para reconocer cambios en los niveles de masa grasa atribuidos a programas de intervención basa-*

show abstract

“…The mechanism behind the role of menopausal risk factors in initiating cardiovascular disease remains unclear [28]. Some studies have been shown that there is no difference in cardiovascular risk factors when comparing pre-menopausal with postmenopausal women [29][30][31][32]. In several studies, the incidences of metabolic syndrome among postmenopausal women were found to be increased in the world [33].…”

Section: Introductionmentioning

confidence: 99%

A Review on Metabolic Syndrome

Marjani

2012

J Endocrinol Metab

View full text Add to dashboard Cite

The metabolic syndrome is described by the clustering of several risk factors for Type 2 diabetes and cardiovascular disease. Lipid disorder, obesity, diabetes in general and high blood pressure are collectively defined as risk factors for cardiovascular disease triggered by metabolic syndrome. The metabolic syndromes have a correlation with the variations in genetic susceptibility, nutritional regiment, physical exercise, chronological age and gender which play direct role in the incidence of metabolic syndrome and its side effects. There are several definitions of Metabolic Syndrome in the World: World Health Organization's (WHO), The NCEP Adult Treatment Panel (ATP) III and the International Diabetes Federation (IDF). It appears that the female type 2 diabetic patients need to change their life style to halt the burden of cardiovascular complications in type 2 diabetic patients. Clinicians should significantly consider screening all people regardless of age for abnormalities in glucose level. Early treatment in people with abnormal glucose level constitutes a strategy of preventing type 2 diabetes mellitus and metabolic syndrome. Studies about metabolic syndrome have shown that females were more affected than males. This may be due to the specific characteristics in the lifestyle changes between females and males diabetic patients. Postmenopausal status might be a predictor of metabolic syndrome. Some related factors of metabolic syndrome among postmenopausal women may increase cardiovascular risk in postmenopausal women.

show abstract

The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women

Abstract: There is a high prevalence of the metabolic syndrome in postmenopausal Latin American women seeking gynecologic health care. Age, years since menopause, obesity and hypertension are strong predictors of this condition.

Cited by 96 publications

References 21 publications

Metabolic syndrome in postmenopausal women: higher prevalence in the Northeastern Region of Brazil than in other Latin American countries and the influence of obesity and socioeconomic factors

Metabolic syndrome in postmenopausal women: higher prevalence in the Northeastern Region of Brazil than in other Latin American countries and the influence of obesity and socioeconomic factors

Correlaciones entre Marcadores de Grasa Abdominal Obtenidos por Densitometría y Técnicas Antropométricas Convencionales en Mujeres Postmenopausicas con Síndrome Metabólico

A Review on Metabolic Syndrome

Contact Info

Product

Resources

About